Long Standing Diabetes on Insulin-Is it Possible to Stop Insulin, Lose Weight and still have Glycaemic Control?
CURRENT RESEARCH IN DIABETES & OBESITY JOURNAL JUNIPER PUBLISHERS Authored by Kalyan Kumar Gangopadhyay Abstract Type 2 diabetes mellitus (T2DM) is a progressive disease and as the disease progresses, insulin therapy becomes necessary in at least 50% of patients with T2DM. The administration of very high insulin doses has inherent challenges including weight gain, absorption problems with high volume of insulin as well as compromising on patient acceptance, comfort and compliance. Thus it is important to have treatment options that combine insulin-sparing agents with insulin to minimize both insulin volume and side effects. The glucagon-like peptide-1 receptor agonists/analogues (GLP-1 RAs) provide an attractive option for the same. Here, I present two cases wherein addition of liraglutide to high dose insulin therapy, relatively late in the disease process, led to complete cessation of insulin therapy as well as weight loss. Go to Case Reports Case 1